Rebecca Cook

Clinical study tests drug that may prevent cancer metastasis

A clinical study of a drug that may block cancer metastasis is currently enrolling patients at the Vanderbilt-Ingram Cancer Center.

Breast cancer-killing RIG

A compound that activates a virus-sensing receptor has potent therapeutic effects in a mouse model of breast cancer.

Drivers of breast cancer metastasis

Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported.

New breast cancer driver

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

Komen, VICC partnership bolsters breast cancer research

For more than twenty years, Vanderbilt-Ingram Cancer Center’s (VICC) primary source of outside funding has been provided by the National Institutes of Health. But in breast cancer, Susan G. Komen, a nonprofit dedicated to breast cancer research and community services, has been a significant sponsor of research and patient care support.

mother and baby

Potential therapy for postpartum breast cancer investigated

Nearly 25 percent of all breast cancers among premenopausal women occur within two to five years following a pregnancy.